In vitro differentiation of endometrial regenerative cells into smooth muscle cells: Α potential approach for the management of pelvic organ prolapse.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 27221348)

Published in Int J Mol Med on May 17, 2016

Authors

Xiuhui Chen1, Xianchao Kong1, Dongzhe Liu2, Peng Gao3, Yanhua Zhang1, Peiling Li1, Meimei Liu1

Author Affiliations

1: Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.
2: Department of Oncology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.
3: Department of Surgery, Harbin Children's Hospital, Harbin, Heilongjiang 150001, P.R. China.

Articles citing this

The effect of stem cell factor on proliferation of human endometrial CD146(+) cells. Int J Reprod Biomed (Yazd) (2016) 0.75

Articles cited by this

Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol (1997) 16.86

Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity. Am J Obstet Gynecol (2002) 5.73

An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn (2010) 5.48

Surgical management of pelvic organ prolapse in women. Cochrane Database Syst Rev (2013) 5.36

TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol Biol Cell (2005) 3.75

Tissue engineering as a potential alternative or adjunct to surgical reconstruction in treating pelvic organ prolapse. Int Urogynecol J (2012) 3.39

Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. Obstet Gynecol (2014) 3.18

Co-expression of two perivascular cell markers isolates mesenchymal stem-like cells from human endometrium. Hum Reprod (2007) 2.37

Endometrial regenerative cells: a novel stem cell population. J Transl Med (2007) 2.19

Transforming growth factor-betas and vascular disorders. Arterioscler Thromb Vasc Biol (2006) 1.99

Proteomic profiling of bone marrow mesenchymal stem cells upon transforming growth factor beta1 stimulation. J Biol Chem (2004) 1.96

The effect of matrix stiffness on the differentiation of mesenchymal stem cells in response to TGF-β. Biomaterials (2011) 1.93

TGF-β/TGF-β receptor system and its role in physiological and pathological conditions. Clin Sci (Lond) (2011) 1.90

Transforming growth factor-beta-induced differentiation of smooth muscle from a neural crest stem cell line. Circ Res (2004) 1.85

Multipotent menstrual blood stromal stem cells: isolation, characterization, and differentiation. Cell Transplant (2008) 1.80

Human bone marrow and adipose tissue mesenchymal stem cells: a user's guide. Stem Cells Dev (2010) 1.78

Treatment of stress urinary incontinence with adipose tissue-derived stem cells. Cytotherapy (2010) 1.71

Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells. Stem Cells (2008) 1.68

Efficacy and safety of using mesh or grafts in surgery for anterior and/or posterior vaginal wall prolapse: systematic review and meta-analysis. BJOG (2008) 1.58

Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. Transfusion (2013) 1.58

Severe mesh complications following intravaginal slingplasty. Obstet Gynecol (2005) 1.56

Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke. Stem Cells Dev (2010) 1.51

Expression of genes encoding smooth muscle contractile proteins in vaginal tissue of women with and without pelvic organ prolapse. Neurourol Urodyn (2011) 1.50

Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine. J Cell Mol Med (2009) 1.49

Differentiation of adipose-derived stem cells promotes regeneration of smooth muscle for ureteral tissue engineering. J Surg Res (2012) 1.45

Characterization of side-population cells in human normal endometrium. Hum Reprod (2007) 1.42

Effects of transforming growth factor-beta 1 and ascorbic acid on differentiation of human bone-marrow-derived mesenchymal stem cells into smooth muscle cell lineage. Cell Tissue Res (2008) 1.29

Morphometric properties of the posterior vaginal wall in women with pelvic organ prolapse. Am J Obstet Gynecol (2002) 1.28

Allogeneic endometrial regenerative cells: an "Off the shelf solution" for critical limb ischemia? J Transl Med (2008) 1.27

Is tissue engineering and biomaterials the future for lower urinary tract dysfunction (LUTD)/pelvic organ prolapse (POP)? Neurourol Urodyn (2011) 1.20

Vaginal degeneration following implantation of synthetic mesh with increased stiffness. BJOG (2013) 1.19

Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy. Cell Immunol (2010) 1.19

Stem cell therapy for stress urinary incontinence: a critical review. Stem Cells Dev (2012) 1.18

Perioperative complications and reoperations after incontinence and prolapse surgeries using prosthetic implants. Obstet Gynecol (2012) 1.17

Human endometrial side population cells exhibit genotypic, phenotypic and functional features of somatic stem cells. PLoS One (2010) 1.17

Feasibility investigation of allogeneic endometrial regenerative cells. J Transl Med (2009) 1.10

Reconstruction of endometrium from human endometrial side population cell lines. PLoS One (2011) 1.10

Muscle derived stem cell therapy for stress urinary incontinence. World J Urol (2008) 1.06

Stem cell therapy: a future treatment of stress urinary incontinence. Semin Reprod Med (2011) 1.03

Pelvic organ distribution of mesenchymal stem cells injected intravenously after simulated childbirth injury in female rats. Obstet Gynecol Int (2011) 1.00

Toward the use of endometrial and menstrual blood mesenchymal stem cells for cell-based therapies. Expert Opin Biol Ther (2013) 0.99

Crucial role of nrf3 in smooth muscle cell differentiation from stem cells. Circ Res (2010) 0.99

Absolute quantitation of endogenous proteins with precision and accuracy using a capillary Western system. Anal Biochem (2013) 0.99

Endometrial regenerative cells for treatment of heart failure: a new stem cell enters the clinic. J Transl Med (2013) 0.96

Comparison of endometrial regenerative cells and bone marrow stromal cells. J Transl Med (2012) 0.92

Developing a tissue engineered repair material for treatment of stress urinary incontinence and pelvic organ prolapse-which cell source? Neurourol Urodyn (2013) 0.91

Stimulating vaginal repair in rats through skeletal muscle-derived stem cells seeded on small intestinal submucosal scaffolds. Obstet Gynecol (2009) 0.90

Qualitative and quantitative evaluation of Simon™, a new CE-based automated Western blot system as applied to vaccine development. Electrophoresis (2012) 0.90

Biological responses to TGF-β in the mammary epithelium show a complex dependency on Smad3 gene dosage with important implications for tumor progression. Mol Cancer Res (2012) 0.89

Mechanisms of TGF-β-induced differentiation in human vascular smooth muscle cells. J Vasc Res (2011) 0.88

Overlapping substrate and inhibitor specificity of human and murine ABCG2. Drug Metab Dispos (2013) 0.88

Adrenomedullin mediates adipose tissue-derived stem cell-induced restoration of erectile function in diabetic rats. J Sex Med (2011) 0.87

Rat mesenchymal stem cell secretome promotes elastogenesis and facilitates recovery from simulated childbirth injury. Cell Transplant (2013) 0.87

Stem cells for stress urinary incontinence: the adipose promise. J Cell Mol Med (2009) 0.86

Fascia tissue engineering with human adipose-derived stem cells in a murine model: Implications for pelvic floor reconstruction. J Formos Med Assoc (2013) 0.85

Induction of endometrial mesenchymal stem cells into tissue-forming cells suitable for fascial repair. Acta Biomater (2014) 0.84

New insights to vascular smooth muscle cell and pericyte differentiation of mouse embryonic stem cells in vitro. Arterioscler Thromb Vasc Biol (2006) 0.84

The proliferation and differentiation of placental-derived multipotent cells into smooth muscle cells on fibrillar collagen. Biomaterials (2010) 0.84

Tissue engineered bulking agent with adipose-derived stem cells and silk fibroin microspheres for the treatment of intrinsic urethral sphincter deficiency. Biomaterials (2013) 0.83

Contractile response of human anterior vaginal muscularis in women with and without pelvic organ prolapse. Reprod Sci (2010) 0.83

Tissue composition of the vaginal wall in women with pelvic organ prolapse. Gynecol Obstet Invest (2012) 0.82

Oxytocin modulates mTORC1 pathway in the gut. Biochem Biophys Res Commun (2013) 0.82

Neuromuscular morphometry of the vaginal wall in women with anterior vaginal wall prolapse. Neurourol Urodyn (2010) 0.81

Human amniotic fluid stem cell differentiation along smooth muscle lineage. FASEB J (2013) 0.81

Characterization of a biopharmaceutical protein and evaluation of its purification process using automated capillary Western blot. Electrophoresis (2014) 0.77